OCD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 50 years old (any gender is welcome)
- You have been diagnosed with OCD (Obsessive-Compulsive Disorder) according to standard diagnostic guidelines
- Your OCD symptoms score 20 or higher on a standard OCD rating scale, despite having tried medication at a proper dose or completing at least one full course of talking therapy (CBT)
- Your current treatment plan has stayed the same for at least 8 weeks before joining, and must remain unchanged during the study
- You have completed more than 9 years of formal education
- You are right-handed
Who may not be able to join:
- You currently have another mental health condition (other than a specific personality disorder related to OCD)
- Your OCD symptoms are so severe that you would be unable to complete the required assessments for the study
- You have previously received electroconvulsive therapy (ECT), a type of brain stimulation treatment
- You have received certain brain stimulation treatments (rTMS or tDCS) in the past two months
- You have a serious physical illness or any condition that could trigger seizures or increased pressure in the brain, such as heart or breathing conditions
- You have a history of neurological conditions (such as epilepsy or stroke), brain injuries, or have had brain surgery
- You have any implanted medical devices, such as a pacemaker, cochlear implant, or certain types of stents
- You are considered to be at serious risk of suicide
- You are currently pregnant or breastfeeding
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhen Wang, PhD，MD, Study Principal Investigato
Phone: +86 34773516
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To explore the differences in treatment efficacy between active and sham dTMS in patients with OCD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.